We conducted a prospective , randomised , controlled , open-label , pilot clinical trial in @ patients fulfilling two of the following three criteria for AHF : ( @ ) left ventricular ejection fraction < @ % , ( @ ) acute pulmonary oedema or respiratory failure of predominantly cardiac origin requiring mechanical ventilation and ( @ ) currently receiving vasopressor and/or inotropic support .